Based on the result of our previous study showing better overall survival ( OS ) at the lower dose ( @ g ) of immunomodulator Z-@ than higher dose ( @ g ) in patients with locally advanced cervical cancer who received radiotherapy , we conducted a placebo-controlled double-blind randomized trial .